Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12 Items
Title  Creator  Group name  Publishing year 
[Resistance to BRAF inhibitors: A lesson from clinical observations] Dahmani et al. EquipePC 2022 Jun-Jul
Proximal Protein Interaction Landscape of RAS Paralogs Béganton et al. EquipePC 2020-11-11
HP1s modulate the S-Adenosyl Methionine synthesis pathway in liver cancer cells Mancini et al. PlateformePP2I Mar 13, 2020
[New approaches for protein-protein interaction study] Béganton et al. EquipePC Mar 2019
Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis Nziza et al. EquipePC Nov 26, 2019
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity Lacombe et al. EquipePC Aug 09, 2019
Protein interactions study through proximity-labeling Béganton et al. PlateformePP2I Aug 2019
FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer Mangé et al. PlateformePP2I 2019
Dzip1 and Fam92 form a ciliary transition zone complex with cell type specific roles in Drosophila Lapart et al. PlateformePP2I 12 10, 2019
Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer Solassol et al. EquipePC 08 28, 2018
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile Valleix et al. PlateformePP2I Jan 21, 2016
An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma Mangé et al. PlateformePP2I 06 16, 2016
12 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés